Influenza and HIV: Lessons from the 2009 H1N1 influenza pandemic

被引：33
作者：
Sheth A.N. [1 ,3 ]
Patel P. [2 ]
Peters P.J. [2 ]
机构：
[1] Department of Medicine, Emory University School of Medicine, Atlanta, GA
[2] Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA
[3] Atlanta, GA 30303
来源：
Current HIV/AIDS Reports | 2011年 / 8卷 / 3期
关键词：
Complications of HIV infection and treatment; Epidemiology; H1N1; Human immunodeficiency virus; Influenza; Pandemic;
D O I：
10.1007/s11904-011-0086-4
中图分类号：
学科分类号：
摘要：
Influenza is a common respiratory disease in adults, including those infected with HIV. In the spring of 2009, a pandemic influenza A (H1N1) virus (pH1N1) emerged. In this article, we review the existing literature regarding pH1N1 virus infection in HIV-infected adults, which suggests that susceptibility to pH1N1 virus infection and severity of influenza illness are likely not increased in HIV-infected adults without advanced immunosuppression or comorbid conditions. The risk of influenza-related complications, however, may be increased in those with advanced immunosuppression or high-risk comorbid conditions. Prevention and treatment of high-risk comorbid conditions and annual influenza vaccination should continue to be part of HIV clinical care to help prevent influenza illness and complications. Additional information about pH1N1 vaccine immunogenicity and efficacy in HIV-infected patients would be useful to guide strategies to prevent influenza virus infection in this population. © Springer Science+Business Media, LLC 2011.
引用
收藏
页码：181 / 191
页数：10
相关论文
共 91 条
[11]  
Report on the global AIDS epidemic, HIV and AIDS Estimates and Data, (2008)
[12]  
Oliveira W., Carmo E., Penna G., Et al., Pandemic H1N1 influenza in Brazil: Analysis of the first 34,506 notified cases of influenza-like illness with severe acute respiratory infection (SARI), Euro Surveill, 14, 42, (2009)
[13]  
Fagard C., Launay O., Boucherie C., Et al., H1N1 pandemic flu: Incidence and characteristics in HIV-infected adults [abstract], 18th Conference on Retroviruses and Opportunistic Infections, (2011)
[14]  
Fiore A.E., Fry A., Shay D., Gubareva L., Bresee J.S., Uyeki T.M., Antiviral agents for the treatment and chemoprophylaxis of influenza - Recommendations of the advisory committee on immunization practices (ACIP), MMWR Surveill Summ, 60, 1, pp. 1-24, (2011)
[15]  
Campos-Loza A., Soto-Ramirez L., Sierra-Madero J., Et al., New swine origin influenza A in HIV-infected patients during the 2009 outbreak in Mexico City, 17th Conference on Retroviruses and Opportunistic Infections, (2010)
[16]  
Martinez E., Marcos M., Hoyo-Ulloa I., Et al., Influenza A H1N1 in HIV-infected adults, HIV Med, 12, 4, pp. 236-245, (2011)
[17]  
Ormsby C.E., De La Rosa-Zamboni D., Vazquez-Perez J., Et al., Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease, AIDS, 25, 4, pp. 435-439, (2011)
[18]  
Arcavi L., Benowitz N.L., Cigarette smoking and infection, Archives of Internal Medicine, 164, 20, pp. 2206-2216, (2004)
[19]  
Isais F., Lye D., Llorin R., Et al., Pandemic (H1N1) 2009 influenza in HIV-infected adults: Clinical features, severity, and outcome, J Infect., 61, 5, pp. 437-440, (2010)
[20]  
Perez C.M., Dominguez M.I., Ceballos M.E., Et al., Pandemic influenza A (H1N1) in HIV-1-infected patients, AIDS, 24, 18, pp. 2867-2869, (2010)
12345678910